英文名稱 |
中文名稱 |
CAS號 |
操作 |
β-NETA |
2-(BETA-萘甲?;?乙基三甲基碘化銨 |
31059-54-8 |
詳細
|
Rivaroxaban impurityA |
利伐沙班雜質A |
865479-71-6 |
詳細
|
Norfloxacin impurity C |
諾氟沙星EP-ZC |
177554-64-2 |
詳細
|
Topiroxostat impurity 20 |
托匹司他Z20 |
161233-97-2 |
詳細
|
Pantothenicacid calciumsalt impurity G |
泛酸鈣EP-ZG |
2140-53-6 |
詳細
|
Tolterodine impurity Z17; 2-(3-amino-1-phenylpropyl)-4-methylphenol hydrochloride |
托特羅定Z17 |
|
詳細
|
formoterol impurity I |
福莫特羅EP-ZI |
67346-50-3 |
詳細
|
Pantothenicacid calciumsalt impurity Z04; ethyl (R)-3-(2,4-dihydroxy-3,3-dimethylbutanamido)propanoate |
泛酸鈣Z04 |
|
詳細
|
Milrinone impurity Z10 |
米力農(nóng)Z10 |
2153433-47-5 |
詳細
|
Rivaroxaban impurityE |
利伐沙班雜質E |
1415566-28-7 |
詳細
|
Tolterodine impurity Z14 |
托特羅定Z14 |
1380491-70-2 |
詳細
|
Rivaroxaban impurityB |
利伐沙班雜質B |
1429334-00-8 |
詳細
|
Topiroxostat impurity 16 |
托匹司他Z14 |
4329-78-6 |
詳細
|
Norfloxacin impurity G |
諾氟沙星EP-ZG |
70459-04-0 |
詳細
|
Milrinone impurity Z05 |
米力農(nóng)Z05 |
80047-38-7 |
詳細
|
Topiroxostat impurity 19 |
托匹司他Z19 |
2044706-68-3 |
詳細
|
Norfloxacin impurity Z13; 9-chloro-6-ethyl-8-fluoro-4-oxo-4,6-dihydro-2H-1l3,2l4-[1,3,2]dioxaborinino[5,6-c]quinoline-2,2-diyl diacetate |
諾氟沙星EP-Z13 |
|
詳細
|
Milrinone impurity Z11 |
米力農(nóng)Z11 |
6302-03-0 |
詳細
|
Tolterodine impurity A |
托特羅定EP-ZA |
124937-73-1 |
詳細
|
Sitagliptin impurity FP-D |
西格列汀FP-D |
1253056-18-6 |
詳細
|
Sitagliptin impurity B |
西格列汀EP-ZB |
486460-31-5 |
詳細
|
Tolterodine impurity Z07 |
托特羅定Z07 |
380636-49-7 |
詳細
|
Rivaroxaban impurityJ |
利伐沙班雜質J |
1632463-24-1 |
詳細
|
formoterol impurity E |
福莫特羅EP-ZE |
1616967-26-0 |
詳細
|
Tolterodine impurity D; N-isopropyl-3-(2-methoxy-5-methylphenyl)-3-phenylpropan-1-amine hydrochloride |
托特羅定EP-ZD |
1391053-65-8 |
詳細
|
Milrinone impurity Z06 |
米力農(nóng)Z06 |
80442-07-5 |
詳細
|
Rivaroxaban impurity01; |
利伐沙班雜質01 |
|
詳細
|
Milrinone impurity Z12 |
米力農(nóng)Z12 |
6302-02-9 |
詳細
|
Topiroxostat impurity 13 |
托匹司他Z13 |
2044706-50-3 |
詳細
|
Rivaroxaban impurity02 |
利伐沙班雜質02 |
1879933-39-7 |
詳細
|
|
Krass 中間體1,G-82a |
2936672-09-0 |
詳細
|
Sitagliptin impurity FP-E |
西格列汀FP-E |
936630-57-8 |
詳細
|
Rivaroxaban impurityF |
利伐沙班雜質F |
24065-33-6 |
詳細
|
Tolterodine impurity Z10 |
托特羅定Z10 |
848768-06-9 |
詳細
|
Topiroxostat impurity 02 |
托匹司他Z02 |
38634-05-8 |
詳細
|
Norfloxacin impurity Z04 |
諾氟沙星EP-Z04 |
75001-63-7 |
詳細
|
formoterol impurity H |
福莫特羅EP-ZH |
1337876-26-2 |
詳細
|
Topiroxostat impurity 01 |
托匹司他Z01 |
2044704-74-5 |
詳細
|
Pantothenicacid calciumsalt impurity C |
泛酸鈣EP-ZC |
599-04-2 |
詳細
|
Tolterodine impurity Z12 |
托特羅定Z12 |
851789-43-0 |
詳細
|
Rivaroxaban impurityD |
利伐沙班雜質D |
1365267-35-1 |
詳細
|
RO5166017 |
化合物 T34373 |
1048346-74-2 |
詳細
|
Topiroxostat impurity 17 |
托匹司他Z17 |
36770-53-3 |
詳細
|
Topiroxostat impurity 10 |
托匹司他Z10 |
577778-82-6 |
詳細
|
Norfloxacin impurity H |
諾氟沙星EP-ZH |
105440-01-5 |
詳細
|
Sitagliptin impurity FP-C |
西格列汀FP-C |
1803026-58-5 |
詳細
|
Topiroxostat impurity 05 |
托匹司他Z05 |
31599-25-4 |
詳細
|
Milrinone impurity Z02 |
米力農(nóng)Z02 |
717818-05-8 |
詳細
|
Topiroxostat impurity 23 |
托匹司他Z23 |
21379-40-8 |
詳細
|
Pantothenicacid calciumsalt impurity H; 3-(5-(1-hydroxy-2-methylpropan-2-yl)-4-oxooxazolidin-3-yl)propanoic acid |
泛酸鈣EP-ZH |
|
詳細
|
Topiroxostat impurity 04; 4,4'-(5,5'-(pyridine-2,4-diyl)bis(4H-1,2,4-triazole-5,3-diyl))dipyridine |
托匹司他Z04 |
|
詳細
|
Topiroxostat impurity 21; 2-cyanoisonicotinamide |
托匹司他Z21 |
98273-47-3 |
詳細
|
Tolterodine impurity Z08 |
托特羅定Z08 |
854306-72-2 |
詳細
|
Norfloxacin impurity J; 6,7-bis(4-(ethoxycarbonyl)piperazin-1-yl)-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
諾氟沙星EP-ZJ |
|
詳細
|
Rivaroxaban impurity03 |
利伐沙班雜質03 |
1365267-37-3 |
詳細
|
Topiroxostat impurity 07 |
托匹司他Z07 |
1992028-94-0 |
詳細
|
formoterol impurity F |
福莫特羅EP-ZF |
1795129-59-7 |
詳細
|
Sitagliptin impurity FP-A |
西格列汀FP-A |
2088771-60-0 |
詳細
|
Topiroxostat impurity 22 |
托匹司他Z22 |
2050015-91-1 |
詳細
|
Topiroxostat impurity 18 |
托匹司他Z18 |
135048-32-7 |
詳細
|
Tolterodine impurity E |
托特羅定EP-ZE |
480432-14-2 |
詳細
|
formoterol impurity B |
福莫特羅EP-ZB |
1224588-66-2 |
詳細
|
formoterol impurity C |
福莫特羅EP-ZC |
1795135-61-3 |
詳細
|
Topiroxostat impurity 24; methyl 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinate |
托匹司他Z24 |
|
詳細
|
Milrinone impurity Z09 |
米力農(nóng)Z09 |
156033-07-7 |
詳細
|
Tolterodine impurity G |
托特羅定EP-ZG |
1554029-91-2 |
詳細
|
Topiroxostat impurity 03 |
托匹司他Z03 |
2044706-78-5 |
詳細
|
Norfloxacin impurity A |
諾氟沙星EP-ZA |
68077-26-9 |
詳細
|
Sitagliptin impurity FP-B |
西格列汀FP-B |
2805078-75-3 |
詳細
|
Tolterodine impurity Z25 |
托特羅定Z25 |
109089-77-2 |
詳細
|
Rivaroxaban impurityH |
利伐沙班雜質H |
1770812-37-7 |
詳細
|
Topiroxostat impurity 14 |
托匹司他Z14 |
6975-73-1 |
詳細
|
β-NETA intermediate |
3-(二甲基氨基)-1-(2-萘)-1-丙酮 |
2752-87-6 |
詳細
|
formoterol impurity G |
福莫特羅EP-ZG |
3706-26-1 |
詳細
|
Tolterodine impurity Z11 |
托特羅定Z11 |
209747-04-6 |
詳細
|
Norfloxacin impurity B |
諾氟沙星EP-ZB |
75001-77-3 |
詳細
|
Topiroxostat impurity 06 |
托匹司他Z06 |
2044702-36-3 |
詳細
|
Rivaroxaban impurity04 |
利伐沙班雜質04 |
1411775-06-8 |
詳細
|
Topiroxostat impurity 12; 2-cyano-4-(3-(1-oxidopyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine 1-oxide |
托匹司他Z12 |
|
詳細
|
Topiroxostat impurity 11 |
托匹司他Z11 |
2044708-04-3 |
詳細
|
Pantothenicacid calciumsalt impurity E |
泛酸鈣EP-ZE |
897045-90-8 |
詳細
|
Pantothenicacid calciumsalt impurity Z05 |
泛酸鈣Z05 |
505-47-5 |
詳細
|
Tolterodine impurity Z09 |
托特羅定Z09 |
40546-94-9 |
詳細
|
Rivaroxaban impurityG |
利伐沙班雜質G |
446292-08-6 |
詳細
|
Rivaroxaban impurityK |
利伐沙班雜質K |
1365267-36-2 |
詳細
|
RO5263397 |
化合物 T12745 |
1357266-05-7 |
詳細
|
Topiroxostat impurity 09 |
托匹司他Z09 |
1841081-71-7 |
詳細
|
Sitagliptin impurity A |
西格列汀EP-ZA |
823817-55-6 |
詳細
|
Sitagliptin impurity C |
西格列汀EP-ZC |
945261-48-3 |
詳細
|
formoterol impurity D |
福莫特羅EP-ZD |
1795133-96-8 |
詳細
|
formoterol impurity A |
福莫特羅EP-ZA |
150513-24-9 |
詳細
|
Milrinone impurity Z07 |
米力農(nóng)Z07 |
106637-42-7 |
詳細
|
Topiroxostat impurity 25; 4-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)picolinohydrazide |
托匹司他Z25 |
|
詳細
|
Pantothenicacid calciumsalt impurity D |
泛酸鈣EP-ZD |
50692-78-9 |
詳細
|
Rivaroxaban impurity05 |
利伐沙班雜質05 |
|
詳細
|
Tolterodine impurity C |
托特羅定EP-ZC |
1161940-88-0 |
詳細
|
Norfloxacin impurity D |
諾氟沙星EP-ZD |
75001-82-0 |
詳細
|
Krass intermediate 01 |
KRAS中間體 |
2936672-10-3 |
詳細
|
Pantothenicacid calciumsalt impurity B |
泛酸鈣EP-ZB |
|
詳細
|
Topiroxostat impurity 28; (Z)-isonicotinohydrazonamide |
托匹司他Z28 |
|
詳細
|